Navigation Links
MEDA Receives FDA Approval of New ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
Date:9/2/2009

d in more than 100 scientific studies. Each metered spray of ASTEPRO Nasal Spray 0.15% delivers 205.5 mcg (micrograms) of azelastine hydrochloride.

Important Information

ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age and older.

For adults and children 12 years of age and older with seasonal allergic rhinitis, the recommended dose of ASTEPRO Nasal Spray 0.15% is 1 or 2 sprays in each nostril twice daily or 2 sprays in each nostril once daily. The recommended dose of ASTEPRO Nasal Spray 0.15% for perennial allergic rhinitis is 2 sprays in each nostril twice daily.

In 2- and 4- week clinical trials for ASTEPRO Nasal Spray 0.15%, the most common adverse reactions reported included bitter taste, nasal discomfort, epistaxis, and sneezing.

Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%.

Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%.

ASTEPRO Nasal Spray 0.1% and 0.15% are available by prescription only.

Please see full prescribing information available at www.astepro.com. For more information, contact Anders Larnholt, VP Corporate Development & Investor Relations at +46 709 458 878.

MEDA AB (publ) is a leading international specialty pharma company. Meda's products are sold in 120 countries worldwide and the company is represented by its own organizations in more than 40 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit '/>"/>

SOURCE Meda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... On the heels of ... the size of its annual health tech innovation program. Now featuring a two-phase ... to compete for cash and prizes to advance their technologies toward commercialization, the ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one ... New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to learn ... at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts (SE) ... Year” awards at this year’s Microsoft Worldwide Partner Conference that was held in ... Year” Award Winner for Data Platform services, the 2015 HP and Microsoft “Outstanding ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way to ... The patent-pending K Med Cups provide a quick and simple way to brew a hot ... flu or cough. As a result, they enhance comfort and health. The invention features a ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... development of its first neighborhood created specifically for adults with intellectual, developmental and ... Phoenix Metro area and feature 30 cottage or “pocket” homes. In this community, ...
Breaking Medicine News(10 mins):Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... First pet food, then tooth paste and now fish. There just ... ,Only two days ago the US put on ... with its finding on whether it contains diethylene glycol, a chemical ... agency is warning that packages of fish imported from China into ...
... of cancer they say will aid the search for cancer-causing ... ,The study was conducted by a team ... at the Dana-Farber Cancer Institute. ,Conventional mouse models ... embryo. , "You plug it into the mouse, ...
... Tower of London has had an iconic status in British ... facing a major pollution threat. ,The entire ... trucks, and the discoloration is most noticeable at the complexs ... Conqueror in 1078, says study co-author Peter Brimblecombe, an atmospheric ...
... agriculture scientist at the University of Missouri-Columbia; is of the ... a good source for cattle feed. , ,In ... the College of Agriculture, is examining the effectiveness of glycerin ... monitor the growth habits of 60 calves from various breeds ...
... of anthrax in Orissa's tribal dominated Koraput district, while ... two days, health officials said Friday. ... 35, of Padiguda village under Semliguda block in Koraput, ... reportedly after consuming cattle meat. ,K.H. Reddy, ...
... Trehan has been reinstated as executive director of the ... week-long row, the hospital announced Saturday. ... the Escorts Heart Institute and Research Centre (EHIRC), Saturday ... and termed his sacking last week as a "result ...
Cached Medicine News:Health News:US Consumers Warned Against Toxic Chinese Fish 2Health News:New Mouse Model to Aid in Cancer-causing Genes Hunt 2Health News:Study Finds Glycerin to Be a Good Source for Cattle Feed 2Health News:Naresh Trehan Reinstated as Chief of Escorts After Weeklong Row 2
(Date:9/3/2015)... -- Cipla, a global pharmaceutical company which uses technology and ... today announced that its UK arm, Cipla EU has ... InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The transaction ... $550 million and will be an all cash transaction. ... million for the year ended Dec 2014 and over ...
(Date:9/3/2015)... -- Report Details What can be expected ... to grow at the fastest rates? Visiongain,s brand new ... trends, opportunities and prospects there. Our 205-page ... most lucrative areas in the industry and the future ... sales at overall world market and regional level. You ...
(Date:9/3/2015)... a population of more than 1 billion, China is ... largest potential market for goods and services. In the ... economies in the average rate of growth in real ... an in vitro diagnostics (IVD) market, China trails only ... European countries, and Japan. China represents one of the ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... April 9, 2008 Dutch biotechnology,company Crucell N.V., ... South,African Tuberculosis Vaccine Initiative (SATVI) present a progress ... tuberculosis vaccine study at the,biennial "Tuberculosis Vaccines for ... today. The study, conducted in Worcester, South,Africa and ...
... NEW YORK, April 9, 2008 Intra-Cellular ... its ongoing development,programs for ITI-007, the Company,s ... (DPPM), and ITI-722,a low-dose formulation of ITI-007, ... disorders, respectively. These new data demonstrate,ITI-007 has ...
Cached Medicine Technology:Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: